Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Viking Global Investors
AddedFeb 13, 2024
UpdatedJun 28, 2026
Viking Global Investors

Viking Global Investors

Operating

Viking Global Investors: A Connecticut-based American hedge fund specializing in venture stages.

Location
Greenwich, CT, US
Founded
1999
Firm
Compare
Portfolio
Employees
Website

Investments

City Therapeutics
City Therapeutics
Series B

Total Raised

$234.5M

Rounds

2

Series B$99.5MJune 2026
AlphaSense
AlphaSense
Series F

Total Raised

$530M

Rounds

2

Series F$350MJune 2026
HI-Bio
HI-Bio

Total Raised

$215M

Rounds

2

Series B$95MJanuary 2024
Lightmatter
Lightmatter

Total Raised

$422M

Rounds

5

Series C$155MDecember 2023
Series C$154MMay 2023
Triveni Bio
Triveni Bio
Series C

Total Raised

$272M

Rounds

3

Series A$92MOctober 2023
DermBiont
DermBiont

Total Raised

$108.5M

Rounds

9

Series B$35.2MOctober 2023
Series A$28MDecember 2021
Allonnia
Allonnia

Total Raised

$90M

Rounds

3

Series A$30MJuly 2023
Ecovative Design
Ecovative Design

Total Raised

$121.1M

Rounds

14

Series E$30MJune 2023
Solarea Bio
Solarea Bio

Total Raised

$26.2M

Rounds

4

Series B$15MMay 2023
ID.me
ID.me

Total Raised

$407.2M

Rounds

22

Series D$132MApril 2023
Pragma Biosciences
Pragma Biosciences

Total Raised

$14.5M

Rounds

7

Series A$10MMarch 2023
Setpoint Medical
Setpoint Medical

Total Raised

$344M

Rounds

12

Series Unknown$80MJanuary 2023
Ensoma
Ensoma

Total Raised

$205M

Rounds

3

Series B$85MJanuary 2023
Mantra Bio
Mantra Bio

Total Raised

$34M

Rounds

3

Series A$9MJanuary 2023
Pearl Health
Pearl Health

Total Raised

$95.5M

Rounds

4

Series B$55.5MDecember 2022
Vector Biomed
Vector Biomed

Total Raised

$15M

Rounds

1

Series Unknown$15MDecember 2022
Arctic Wolf Networks
Arctic Wolf Networks

Total Raised

$899.2M

Rounds

9

Convertible Note$401MOctober 2022
Locus Biosciences
Locus Biosciences

Total Raised

$118.7M

Rounds

10

Series B$35MMay 2022
Revenova
Revenova

Total Raised

$63M

Rounds

1

Series Unknown$63MApril 2022
BiomEdit
BiomEdit

Total Raised

$44.5M

Rounds

2

Series A$40MApril 2022
Standard BioTools
Standard BioTools
Public

Total Raised

$375.2M

Rounds

9

Post Ipo Equity$250MJanuary 2022
Xcell Biosciences
Xcell Biosciences
Series B

Total Raised

$39.6M

Rounds

4

Series B$27.5MJanuary 2022
Mythic Therapeutics
Mythic Therapeutics

Total Raised

$126.6M

Rounds

3

Series B$103MDecember 2021